Global Blood Purification Equipment Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Indication;

Sepsis, Renal Diseases, and Others

By Type;

Portable and Stationary

By Procedure;

Dialysis, Continuous Renal Replacement Therapy (CRRT), and Others

By Application;

Continuous Blood Purification, Hemoperfusion, and Hemodialysis

By End User;

Hospitals, Clinics, and Others

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn159410757 Published Date: June, 2025 Updated Date: July, 2025

Blood Purification Equipment Market Overview

Blood Purification Equipment Market (USD Million)

Blood Purification Equipment Market was valued at USD 4,694.53 million in the year 2024. The size of this market is expected to increase to USD 6,244.51 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 4.2%.


Global Blood Purification Equipment Market Growth, Share, Size, Trends and Forecast

*Market size in USD million

CAGR 4.2 %


Study Period2025 - 2031
Base Year2024
CAGR (%)4.2 %
Market Size (2024)USD 4,694.53 Million
Market Size (2031)USD 6,244.51 Million
Market ConcentrationHigh
Report Pages375
4,694.53
2024
6,244.51
2031

Major Players

  • Accel Diagnostics LLC
  • Aethlon Medical Inc
  • Cerus Corp
  • Circle Biologics LLC
  • CytoSorbents Corp
  • Jafron
  • Medtronic
  • NxStage Medical Inc
  • Spectral Medical Inc
  • Stellarray

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Global Blood Purification Equipment Market

Fragmented - Highly competitive market without dominant players


The Blood Purification Equipment Market is expanding significantly as chronic health conditions like kidney disease, autoimmune disorders, and sepsis become increasingly prevalent. Around 45% of people globally are affected by long-term diseases, creating consistent demand for efficient blood detoxification systems. These devices are essential in removing harmful substances from the bloodstream in acute and chronic care scenarios.

Technological Breakthroughs Strengthen Market Potential
Innovations in filtration, adsorption, and dialysis technologies have drastically improved treatment precision. Modern systems provide 30% higher removal rates of toxins and inflammatory mediators than older models. The addition of smart sensors and automated controllers is also enhancing the efficiency and safety of blood purification therapies.

Critical Care Units Driving Equipment Uptake
Use of blood purification devices is growing within intensive care units, where they are crucial for managing complex cases like sepsis and organ failure. Nearly 50% of ICUs are now equipped with these systems. Their ability to reduce mortality by improving hemodynamic stability makes them a preferred intervention in emergency and critical care.

Expanding Use Beyond Renal Disorders
Blood purification is no longer confined to kidney-related conditions. Today, 35% of advanced medical institutions are applying these therapies in cases such as autoimmune diseases and critical infections. The growing recognition of their broader clinical utility is driving adoption across diverse treatment landscapes.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Indication
    2. Market Snapshot, By Type
    3. Market Snapshot, By Procedure

    4. Market Snapshot, By Application

    5. Market Snapshot, By End User
    6. Market Snapshot, By Region
  4. Blood Purification Equipment Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Chronic kidney disease (CKD)
        2. Acute kidney injury (AKI)
        3. Rising prevalence of diabetes and hypertension
        4. Aging population
      2. Restraints
        1. High cost of equipment and treatments
        2. Limited reimbursement coverage in certain regions
        3. Stringent regulatory requirements and compliance standards
        4. Shortage of skilled healthcare professionals
      3. Opportunities
        1. Technological innovation
        2. Emerging markets
        3. Home-based devices
        4. Collaborations in research
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Blood Purification Equipment Market, By Indication, 2021 - 2031 (USD Million)

      1. Sepsis

      2. Renal Disease

      3. Others

    2. Blood Purification Equipment Market, By Type, 2021 - 2031 (USD Million)

      1. Portable

      2. Stationary

    3. Blood Purification Equipment Market, By Procedure, 2021 - 2031 (USD Million)
      1. Dialysis

      2. Continuous Renal Replacement Therapy (CRRT)

      3. Others

    4. Blood Purification Equipment Market, By Application, 2021 - 2031 (USD Million)
      1. Continuous Blood Purification
      2. Hemoperfusion
      3. Hemodialysis
    5. Blood Purification Equipment Market, By End User, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Clinics
      3. Others
    6. Blood Purification Equipment Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Accel Diagnostics LLC
      2. Aethlon Medical Inc
      3. Cerus Corp
      4. Circle Biologics LLC
      5. CytoSorbents Corp
      6. Jafron
      7. Medtronic
      8. NxStage Medical Inc
      9. Spectral Medical Inc
      10. Stellarray
  7. Analyst Views
  8. Future Outlook of the Market